Bjertnaes, Oyvind
Skudal, Kjersti E.
van den Berg, Michael J.
Porter, Ian
Holmboe, Olaf
Norman, Rebecka M.
Iversen, Hilde H.
Ellingsen-Dalskau, Lina H.
Valderas, Jose M.
Funding for this research was provided by:
Norwegian Institute of Public Health
Article History
Received: 1 August 2023
Accepted: 14 October 2024
First Online: 18 October 2024
Declarations
:
: The study was part of a national quality assurance project (“OECDs Patient-reported Indicator survey in Norway 2021-25”, project number: 3103). Research Director Atle Fretheim of the NIPH healthcare services division approved the Data Protection Impact Assessment (DPIA) for the quality assurance project. According to the joint body of the Norwegian Regional Committees for Medical and Health Research Ethics, research approval is not required for quality assurance projects. Informed consent was obtained for all participants. Returning the completed questionnaire constituted patient consent, which is the standard procedure in all patient-experience surveys conducted by the Norwegian Institute of Public Health. Patients were informed that participation was voluntary. The study was performed in accordance with relevant guidelines and regulations including the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.